ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Five-Tier, Phase 2 Open-Label Study of IMC-A12 Administered as a Single Agent

This study is currently recruiting participants.
Study NCT00668148.   Last updated on October 14, 2008.   Information provided by ImClone Systems
Please refer to this study by its ClinicalTrials.gov identifier: NCT00668148


Contacts
Contact: Paul Windt     908-541-8151     paul.windt@imclone.com    

Locations
United States, Colorado
University of Colorado at Denver and Health Sciences Center     Recruiting
      Aurora, Colorado, United States, 80045
      Principal Investigator: Anthony Elias, MD            
The Children's Hospital     Recruiting
      Aurora, Colorado, United States, 80045
      Principal Investigator: Lia Gore, MD            
United States, Florida
MD Anderson Cancer Center Orlando     Recruiting
      Orlando, Florida, United States, 32806
      Contact: Meg Caldwell     321-841-6653        
      Principal Investigator: Gregory K Pennock, MD            
United States, Michigan
Wayne State University     Recruiting
      Detroit, Michigan, United States, 48201-2014
      Principal Investigator: Shirish Gadgeel, MD            
United States, Missouri
Washington University School of Medicine     Recruiting
      St Louis, Missouri, United States, 63110
      Principal Investigator: Douglas Adkins            
Washington University School of Medicine     Recruiting
      St Louis, Missouri, United States, 63 110
      Principal Investigator: Douglas Adkins, MD            

Sponsors and Collaborators
ImClone Systems





Links to all studies - primarily for crawlers